OTTMUSG00000010332 Activators
Understanding the general principles of protein activation and the cellular signaling pathways can provide insights into potential mechanisms of Gm13088 activation. Proteins like Gm13088 are typically activated through post-translational modifications, such as phosphorylation. Phosphorylation alters the protein's conformation, enabling it to interact with other cellular components or perform its enzymatic functions more effectively. The activation of Gm13088, therefore, could logically occur through kinase pathways that lead to its phosphorylation. The kinases, such as Protein Kinase A (PKA), Protein Kinase C (PKC), and calmodulin-dependent kinase (CaMK), play crucial roles in these processes. These kinases are activated by various cellular signals, such as increases in cyclic AMP (cAMP) or calcium ion levels, and can modify the activity of a wide range of substrates, including proteins like Gm13088.
The chemicals listed in the table are known to influence these signaling pathways. For instance, compounds that increase cAMP levels, like Forskolin and Rolipram, activate PKA, which can phosphorylate and activate many proteins. Similarly, increases in intracellular calcium levels, as induced by Ionomycin, activate CaMK, another kinase potentially capable of activating Gm13088. In addition, modulation of cGMP levels by Sildenafil or Zaprinast can activate Protein Kinase G (PKG), which could also play a role in the phosphorylation and activation of Gm13088. Given the complexity of cellular signaling networks, the precise mechanism of Gm13088 activation by these chemicals may involve direct interactions or more indirect effects through the modulation of related pathways. It's important to note that while these hypotheses are grounded in established biochemical principles, experimental validation is essential to confirm the specific role and mechanism of these chemicals in activating Gm13088. This approach aligns with the scientific method, where hypotheses based on current knowledge guide experimental investigations to uncover new insights into biological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate and activate several downstream proteins. This activation cascade can lead to the activation of Gm13088 by promoting its phosphorylation. The precise mechanism may involve direct phosphorylation or alteration of the cellular environment that favors Gm13088 activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which can phosphorylate and activate numerous proteins. This cascade potentially leads to the activation of Gm13088 by altering its phosphorylation state or by modulating the activity of proteins interacting with Gm13088. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 (PDE4) inhibitor. By inhibiting PDE4, Rolipram increases cAMP levels in cells, leading to PKA activation. PKA can then potentially activate Gm13088 through phosphorylation, thereby enhancing its functional activity within the cell. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a major component of green tea, has been shown to modulate various signaling pathways. It may activate Gm13088 by modulating kinase activities or cellular signaling cascades that lead to the phosphorylation and activation of Gm13088, thereby enhancing its function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable analog of cAMP that activates PKA. Upon entering the cell, it can elevate PKA activity, which in turn could phosphorylate and activate Gm13088, leading to its functional activation through conformational changes or interaction with other proteins. | ||||||
8-CPT-cAMP | 93882-12-3 | sc-201569 sc-201569A | 20 mg 100 mg | $87.00 $316.00 | 19 | |
8-CPT-cAMP is a potent and selective activator of the cAMP-dependent PKA pathway. Activation of PKA could lead to the phosphorylation and activation of Gm13088, thereby enhancing its functional activity within cellular signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate JNK (c-Jun N-terminal Kinase) signaling pathways. Activation of JNK can lead to the activation of several downstream proteins, potentially including Gm13088, by altering their phosphorylation state or modulating the cellular environment conducive to Gm13088 activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases but at low concentrations can act as an activator. It may indirectly activate Gm13088 through its effects on kinase pathways, possibly by influencing the phosphorylation state or interaction of Gm13088 with other cellular proteins. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, leading to increased cGMP levels. This elevation can activate PKG, potentially leading to the phosphorylation and activation of Gm13088. This activation could be direct or via modulation of other cellular proteins that interact with Gm13088. | ||||||